Research showed links between smoking heavily and developing genetic mutations and a greater risk for myelodysplastic ...
Important Note: All contributions to this Research Topic must be within the scope of the section and journal to which they are submitted, as defined in their mission statements. Frontiers reserves the ...
Three clinical trials led by researchers from The University of Texas MD Anderson Cancer Center demonstrated significant ...
The relationship between heteroplasmy and clonal hematopoiesis of indeterminate potential and its association with the incidence of myeloid neoplasms ... in patients with myelodysplastic syndromes ...
Fedratinib can reduce symptoms and spleen volume in patients with myelodysplastic syndrome (MDS) or myeloproliferative neoplasms (MPNs), according to research presented at the ASH Annual Meeting 2024.
SAN DIEGO ― Three clinical trials led by researchers from The University of Texas MD Anderson Cancer Center demonstrated ...
Improvements in Hematological Parameters and Quality of Life (QOL) with Elritercept (KER-050): Results from an Ongoing Phase 2 Trial in Participants with Lower-Risk (LR) Myelodysplastic Neoplasms ...
A new thesis from Karolinska Institutet shows the effectiveness of flexible parametric survival models in modeling multiple ...
The models were tested ... The risk for COVID-19 hospitalization is low in adults with acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS), but these individuals have a high mortality ...
The models were tested in the context of myeloproliferative neoplasms, a group of chronic ... transformation to acute myeloid leukemia and myelodysplastic syndromes. In her thesis, doctoral ...